Ignite Creation Date:
2024-05-06 @ 4:57 PM
Last Modification Date:
2024-10-26 @ 2:19 PM
Study NCT ID:
NCT05141292
Status:
RECRUITING
Last Update Posted:
2022-02-04
First Post:
2021-11-19
Brief Title:
A Registry Study of Biomarkers in Mitral Valve Disease BIOMS-MVD
Sponsor:
Beijing Institute of Heart Lung and Blood Vessel Diseases
Organization:
Beijing Institute of Heart Lung and Blood Vessel Diseases
Study Overview
Official Title:
A Registry Study of Biomarkers in Mitral Valve Disease
Status:
RECRUITING
Status Verified Date:
2022-01
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
The registry study aims to discover the prognostic value of bio-markers in mitral valve disease
Detailed Description:
The purpose of this study is to investigate the prognostic value of biomarkers in mitral valve diseasePatients with confirmed diagnosis of mitral valve disease are enrolledThe primary outcome is all-cause mortality based on the death certificates The secondary outcome is readmission for heart failure and all-cause mortalityreadmission for heart failure according to the patients medical records
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
False
Is a FDA Regulated Device?:
False
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None